These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 17406138)

  • 1. Is second-line enuretic alarm therapy after unsuccessful pharmacotherapy superior to first-line therapy in the treatment of monosymptomatic nocturnal enuresis?
    Tuygun C; Eroglu M; Bakirtas H; Gucuk A; Zengin K; Imamoglu A
    Urol Int; 2007; 78(3):260-3. PubMed ID: 17406138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of long-term efficacy of desmopressin lyophilisate and enuretic alarm for monosymptomatic enuresis and assessment of predictive factors for success: a randomized prospective trial.
    Önol FF; Guzel R; Tahra A; Kaya C; Boylu U
    J Urol; 2015 Feb; 193(2):655-61. PubMed ID: 25158273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term follow-up of enuretic alarm treatment in enuresis nocturna.
    Tuncel A; Mavituna I; Nalcacioglu V; Tekdogan U; Uzun B; Atan A
    Scand J Urol Nephrol; 2008; 42(5):449-54. PubMed ID: 18609270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy of an enuresis alarm in monosymptomatic nocturnal enuresis.
    Ozgür BC; Ozgür S; Doğan V; Orün UA
    Singapore Med J; 2009 Sep; 50(9):879-80. PubMed ID: 19787175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective evaluation of factors affecting the response and relapse rates to desmopressin therapy in male monosymptomatic enuretic adults.
    Burgu B; Gökce MI; Gücük A; Soygür T
    Urology; 2009 Oct; 74(4):915-9. PubMed ID: 19643460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of the enuresis alarm and desmopressin: second line treatment for nocturnal enuresis.
    Kamperis K; Hagstroem S; Rittig S; Djurhuus JC
    J Urol; 2008 Mar; 179(3):1128-31. PubMed ID: 18206924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of desmopressin and enuresis alarm as first and second line treatment for primary monosymptomatic nocturnal enuresis: prospective randomized crossover study.
    Kwak KW; Lee YS; Park KH; Baek M
    J Urol; 2010 Dec; 184(6):2521-6. PubMed ID: 20961574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of different modes of combined therapy in children with monosymptomatic nocturnal enuresis.
    Vogt M; Lehnert T; Till H; Rolle U
    BJU Int; 2010 May; 105(10):1456-9. PubMed ID: 19764973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of the bell and pad alarm therapy for nocturnal enuresis.
    Gim CS; Lillystone D; Caldwell PH
    J Paediatr Child Health; 2009; 45(7-8):405-8. PubMed ID: 19712175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracorporeal magnetic innervation therapy in children with refractory monosymptomatic nocturnal enuresis.
    Kang SH; Bae JH; Shim KS; Park HS; Cheon J; Lee JG; Yoon DK; Kim JJ; Moon du G
    Urology; 2007 Sep; 70(3):576-80. PubMed ID: 17905120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of desmopressin combined with alarm therapy for monosymptomatic nocturnal enuresis.
    Leebeek-Groenewegen A; Blom J; Sukhai R; Van Der Heijden B
    J Urol; 2001 Dec; 166(6):2456-8. PubMed ID: 11696811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination therapy with alarm and drugs for monosymptomatic nocturnal enuresis not superior to alarm monotherapy.
    Naitoh Y; Kawauchi A; Yamao Y; Seki H; Soh J; Yoneda K; Mizutani Y; Miki T
    Urology; 2005 Sep; 66(3):632-5. PubMed ID: 16140092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desmopressin and oxybutynin in monosymptomatic nocturnal enuresis: a randomized, double-blind, placebo-controlled trial and an assessment of predictive factors.
    Montaldo P; Tafuro L; Rea M; Narciso V; Iossa AC; Del Gado R
    BJU Int; 2012 Oct; 110(8 Pt B):E381-6. PubMed ID: 22313792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structured desmopressin withdrawal improves response and treatment outcome for monosymptomatic enuretic children.
    Marschall-Kehrel D; Harms TW;
    J Urol; 2009 Oct; 182(4 Suppl):2022-6. PubMed ID: 19695616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of primary nocturnal enuresis persisting into adulthood.
    Vandersteen DR; Husmann DA
    J Urol; 1999 Jan; 161(1):90-2. PubMed ID: 10037376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure of monotherapy in primary monosymptomatic enuresis: a combined desmopressin and propiverine treatment regimen improves efficacy outcomes.
    Alloussi SH; Mürtz G; Gitzhofer S; Eichel R; Lang C; Madersbacher H; Strugala G; Alloussi S
    BJU Int; 2009 Jun; 103(12):1706-12. PubMed ID: 19154456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary monosymptomatic nocturnal enuresis in children and adolescents.
    Lottmann HB; Alova I
    Int J Clin Pract Suppl; 2007 Sep; (155):8-16. PubMed ID: 17727574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The evaluation of urinary tract dysfunction in children with monosymptomatic primary nocturnal enuresis].
    Korzeniecka-Kozerska A; Zoch-Zwierz W; Wasilewska A; Porowski T
    Pol Merkur Lekarski; 2008; 24 Suppl 4():56-60. PubMed ID: 18924504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nocturnal enuresis and the use of desmopressin: is it helpful?
    Bath R; Morton R; Uing A; Williams C
    Child Care Health Dev; 1996 Mar; 22(2):73-84. PubMed ID: 8820012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of a tertiary center enuresis population, with special emphasis on the relation among nocturnal diuresis, functional bladder capacity and desmopressin response.
    Dehoorne JL; Walle CV; Vansintjan P; Raes AM; De Guchtenaere AR; Van Laecke E; Hoebeke P; Vande Walle JG
    J Urol; 2007 Mar; 177(3):1130-7. PubMed ID: 17296432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.